Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
Standardized Application of Feeding Evaluations Using SMART Tool
for
Infant and Young Child Feeding
Location: Milwaukee WI, West Allis WI, Grafton WI, Summit WI,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 0 - 1
Code: NCT07136610
Recruiting
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase3, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Waukesha WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Oak Creek WI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
for
Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06002828
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase3, Recruiting
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
for
Cancer
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18+
Code: NCT06756607
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
for
Advanced Esophageal Adenocarcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06203600
Phase2, Phase3, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase2, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase2, Phase3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Oak Creek WI,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase3, Recruiting
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03191149
Phase2, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase2, Phase3, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase3, Recruiting
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
for
Malignancy
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Cudahy WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Milwaukee WI, West Allis WI, Wauwatosa WI, Waukesha WI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer